The delineation of the full repertoire of AMPK targets and mechanisms involved in the beneficial effects of exercise on muscle mitochondrial metabolism has implications for therapeutic approaches for many human diseases, including metabolic disorders and muscular dystrophy. Here, PRKAA1 is linked to metabolic disease.